• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脓毒症的分子内型:基于RNA测序的多队列转录组学整合

Molecular endotypes in sepsis: integration of multicohort transcriptomics based on RNA sequencing.

作者信息

Mekata Kengo, Kyo Michihito, Tan Modong, Shime Nobuaki, Hirohashi Nobuyuki

机构信息

Department of Radiation Disaster Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

出版信息

J Intensive Care. 2025 May 30;13(1):30. doi: 10.1186/s40560-025-00802-1.

DOI:10.1186/s40560-025-00802-1
PMID:40448231
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12123803/
Abstract

BACKGROUND

The heterogeneity of host responses in sepsis has hindered efforts to develop targeted therapies for this large patient population. Although growing evidence has identified sepsis endotypes based on the microarray data, studies using RNA-seq data-which offers higher sensitivity and a broader dynamic range-remain limited. We hypothesized that integrating RNA-seq data from patients with sepsis would reveal molecular endotypes with distinct biological and clinical signatures.

METHODS

In this meta-analysis, we systematically searched for publicly available RNA-seq datasets of sepsis. Using identified datasets, we applied a consensus clustering algorithm to identify distinct endotypes. To characterize the biological differences between these endotypes, we performed gene-set enrichment analysis and immune cell deconvolution. Next, we investigated the association between these endotypes and mortality risks. We finally developed gene classifiers for endotype stratification and validated our endotype classification by applying these classifiers to an external cohort.

RESULTS

A total of 280 adults with sepsis from four datasets were included in this analysis. Using an unsupervised approach, we identified three distinct endotypes: coagulopathic (n = 83, 30%), inflammatory (n = 118, 42%), and adaptive endotype (n = 79, 28%). The coagulopathic endotype exhibited upregulated coagulation signaling, along with an increased monocyte and neutrophil composition, although the adaptive endotype demonstrated enhanced adaptive immune cell responses, marked by elevated T and B cell compositions. The inflammatory endotype was characterized by upregulated TNF-α/NF-κB signaling and IL-6/JAK/STAT3 pathways with an increased neutrophil composition. Patients with the coagulopathic endotype had a significantly higher risk of mortality than those with the adaptive endotype (30% vs. 16%, odds ratio 2.19, 95% confidence interval 1.04-4.78, p = 0.04). To enable the practical application of these findings, we developed endotype classification models and identified 14 gene classifiers. In a validation cohort of 123 patients, we consistently identified these three endotypes. Furthermore, the mortality risk pattern was reproduced, with the coagulopathic endotype showing greater mortality risk than the adaptive endotype (34% vs 18%, p = 0.10).

CONCLUSIONS

This multicohort RNA-seq meta-analysis identified three biologically and clinically distinct sepsis endotypes characterized by coagulopathic, adaptive, and inflammatory responses. This endotype-based approach to patient stratification may facilitate the development of more precise therapeutic strategies for sepsis.

摘要

背景

脓毒症患者宿主反应的异质性阻碍了针对这一庞大患者群体开发靶向治疗方法的努力。尽管越来越多的证据已基于微阵列数据确定了脓毒症的内型,但使用RNA测序数据(其具有更高的灵敏度和更宽的动态范围)的研究仍然有限。我们假设整合脓毒症患者的RNA测序数据将揭示具有不同生物学和临床特征的分子内型。

方法

在这项荟萃分析中,我们系统地搜索了公开可用的脓毒症RNA测序数据集。使用已确定的数据集,我们应用了一致性聚类算法来识别不同的内型。为了表征这些内型之间的生物学差异,我们进行了基因集富集分析和免疫细胞反卷积。接下来,我们研究了这些内型与死亡风险之间的关联。我们最终开发了用于内型分层的基因分类器,并通过将这些分类器应用于外部队列来验证我们的内型分类。

结果

本分析共纳入了来自四个数据集的280名成年脓毒症患者。使用无监督方法,我们确定了三种不同的内型:凝血病型(n = 83,30%)、炎症型(n = 118,42%)和适应性内型(n = 79,28%)。凝血病型内型表现出凝血信号上调,同时单核细胞和中性粒细胞组成增加,而适应性内型则表现出适应性免疫细胞反应增强,以T细胞和B细胞组成增加为特征。炎症型内型的特征是TNF-α/NF-κB信号通路和IL-6/JAK/STAT3通路上调,中性粒细胞组成增加。凝血病型内型的患者死亡风险显著高于适应性内型患者(30%对16%,优势比2.19,95%置信区间1.04 - 4.78,p = 0.04)。为了使这些发现能够实际应用,我们开发了内型分类模型并确定了14个基因分类器。在一个123名患者的验证队列中,我们一致识别出了这三种内型。此外,死亡风险模式得以重现,凝血病型内型的死亡风险高于适应性内型(34%对18%,p = 0.10)。

结论

这项多队列RNA测序荟萃分析确定了三种在生物学和临床上不同的脓毒症内型,其特征为凝血病性、适应性和炎症反应。这种基于内型的患者分层方法可能有助于为脓毒症开发更精确的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ab/12123803/25c0042705fb/40560_2025_802_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ab/12123803/333f55bc7a77/40560_2025_802_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ab/12123803/0b1313e30713/40560_2025_802_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ab/12123803/fe4ca7e8dd8d/40560_2025_802_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ab/12123803/25c0042705fb/40560_2025_802_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ab/12123803/333f55bc7a77/40560_2025_802_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ab/12123803/0b1313e30713/40560_2025_802_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ab/12123803/fe4ca7e8dd8d/40560_2025_802_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ab/12123803/25c0042705fb/40560_2025_802_Fig4_HTML.jpg

相似文献

1
Molecular endotypes in sepsis: integration of multicohort transcriptomics based on RNA sequencing.脓毒症的分子内型:基于RNA测序的多队列转录组学整合
J Intensive Care. 2025 May 30;13(1):30. doi: 10.1186/s40560-025-00802-1.
2
Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study.根据血液基因组内型对脓毒症患者进行分类:一项前瞻性队列研究。
Lancet Respir Med. 2017 Oct;5(10):816-826. doi: 10.1016/S2213-2600(17)30294-1. Epub 2017 Aug 29.
3
Predicting sepsis severity at first clinical presentation: The role of endotypes and mechanistic signatures.预测首发临床症状的脓毒症严重程度:内表型和机制特征的作用。
EBioMedicine. 2022 Jan;75:103776. doi: 10.1016/j.ebiom.2021.103776. Epub 2022 Jan 10.
4
Defining critical illness using immunological endotypes in patients with and without sepsis: a cohort study.使用免疫内型定义合并和不合并脓毒症的危重病患者:一项队列研究。
Crit Care. 2023 Jul 20;27(1):292. doi: 10.1186/s13054-023-04571-x.
5
Gene expression signatures identify biologically and clinically distinct tuberculosis endotypes.基因表达特征可识别生物学和临床特征不同的结核病表型。
Eur Respir J. 2022 Sep 15;60(3). doi: 10.1183/13993003.02263-2021. Print 2022 Sep.
6
Validation of Inflammopathic, Adaptive, and Coagulopathic Sepsis Endotypes in Coronavirus Disease 2019.验证 2019 年冠状病毒病的炎症型、适应性和凝血异常型败血症。
Crit Care Med. 2021 Feb 1;49(2):e170-e178. doi: 10.1097/CCM.0000000000004786.
7
Defining critical illness using immunological endotypes in patients with and without of sepsis: A cohort study.使用免疫内型对脓毒症患者和非脓毒症患者的危重症进行定义:一项队列研究。
Res Sq. 2023 May 8:rs.3.rs-2874506. doi: 10.21203/rs.3.rs-2874506/v1.
8
A Transcriptomic Classifier Model Identifies High-Risk Endotypes in a Prospective Study of Sepsis in Uganda.一项针对乌干达脓毒症的前瞻性研究表明,转录组分类器模型可识别高危表型。
Crit Care Med. 2024 Mar 1;52(3):475-482. doi: 10.1097/CCM.0000000000006023. Epub 2023 Aug 7.
9
Transitions of blood immune endotypes and improved outcome by anakinra in COVID-19 pneumonia: an analysis of the SAVE-MORE randomized controlled trial.COVID-19 肺炎中血液免疫终末表型的转变和 anakinra 的改善结局:SAVE-MORE 随机对照试验分析。
Crit Care. 2024 Mar 12;28(1):73. doi: 10.1186/s13054-024-04852-z.
10
Complementary role of transcriptomic endotyping and protein-based biomarkers for risk stratification in sepsis-associated acute kidney injury.转录组内型分析和基于蛋白质的生物标志物在脓毒症相关急性肾损伤风险分层中的互补作用。
Crit Care. 2025 Mar 26;29(1):136. doi: 10.1186/s13054-025-05361-3.

本文引用的文献

1
edgeR v4: powerful differential analysis of sequencing data with expanded functionality and improved support for small counts and larger datasets.edgeR v4:具有扩展功能且对小计数和更大数据集提供更好支持的强大测序数据差异分析工具。
Nucleic Acids Res. 2025 Jan 11;53(2). doi: 10.1093/nar/gkaf018.
2
Sepsis endotypes identified by host gene expression across global cohorts.通过全球队列中宿主基因表达鉴定的脓毒症内型。
Commun Med (Lond). 2024 Jun 18;4(1):120. doi: 10.1038/s43856-024-00542-7.
3
From ICU Syndromes to ICU Subphenotypes: Consensus Report and Recommendations for Developing Precision Medicine in the ICU.
从 ICU 综合征到 ICU 亚表型:精准医学在 ICU 中的发展共识报告和建议。
Am J Respir Crit Care Med. 2024 Jul 15;210(2):155-166. doi: 10.1164/rccm.202311-2086SO.
4
The 'analysis of gene expression and biomarkers for point-of-care decision support in Sepsis' study; temporal clinical parameter analysis and validation of early diagnostic biomarker signatures for severe inflammation andsepsis-SIRS discrimination.用于脓毒症即时决策支持的基因表达和生物标志物分析研究;严重炎症和脓毒症-全身炎症反应综合征鉴别诊断的即时临床参数分析和早期诊断生物标志物特征验证。
Front Immunol. 2024 Jan 25;14:1308530. doi: 10.3389/fimmu.2023.1308530. eCollection 2023.
5
Uncovering heterogeneity in sepsis: a comparative analysis of subphenotypes.揭示脓毒症的异质性:亚表型的比较分析。
Intensive Care Med. 2023 Nov;49(11):1360-1369. doi: 10.1007/s00134-023-07239-w. Epub 2023 Oct 18.
6
Persistence is key: unresolved immune dysfunction is lethal in both COVID-19 and non-COVID-19 sepsis.坚持是关键:未解决的免疫功能障碍在 COVID-19 和非 COVID-19 败血症中都是致命的。
Front Immunol. 2023 Sep 26;14:1254873. doi: 10.3389/fimmu.2023.1254873. eCollection 2023.
7
Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials.鉴定脓毒症的分子表型:两项前瞻性观察队列研究的分析和两项随机对照试验的二次分析。
Lancet Respir Med. 2023 Nov;11(11):965-974. doi: 10.1016/S2213-2600(23)00237-0. Epub 2023 Aug 23.
8
The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation.脓毒症相关弥散性血管内凝血的病理生理学、诊断及管理
J Intensive Care. 2023 May 23;11(1):24. doi: 10.1186/s40560-023-00672-5.
9
Endothelial dysfunction and immunothrombosis in sepsis.脓毒症中的内皮功能障碍与免疫血栓形成。
Front Immunol. 2023 Apr 4;14:1144229. doi: 10.3389/fimmu.2023.1144229. eCollection 2023.
10
Predicting sepsis severity at first clinical presentation: The role of endotypes and mechanistic signatures.预测首发临床症状的脓毒症严重程度:内表型和机制特征的作用。
EBioMedicine. 2022 Jan;75:103776. doi: 10.1016/j.ebiom.2021.103776. Epub 2022 Jan 10.